FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...